Safety and effectiveness of GRAIL system for enlarged prostate
Part of Kidney & urinary clinical trials.
This trial tests a new minimally invasive treatment device called the ALPFA GRAIL System to see if it safely and effectively reduces urinary symptoms caused by an enlarged prostate. The procedure aims to improve urinary flow and reduce bothersome symptoms like frequent urination.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 45 years old
- You have moderate to severe urinary symptoms from an enlarged prostate (measured by a symptom score test)
- Your prostate is between 25–150 grams in size (checked by ultrasound)
- You have not had previous prostate surgery or treatments for enlarged prostate
- You are willing to stop certain medications (like prostate medications or blood thinners) before and after the procedure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a drug called adalimumab (a TNF blocker) can improve symptoms of an enlarged prostate. It is for men aged 45-80 with a large prostate and bothersome urinary symptoms who have not used this type of medication before.
This study compares two minimally invasive devices (iTind and UroLift) to treat urinary symptoms caused by an enlarged prostate. It is for men whose symptoms are bothersome enough to need treatment.
This trial tests a new device that uses pulsed electric fields to shrink an enlarged prostate (benign prostatic hyperplasia, or BPH). It's for men who have tried medication but still have bothersome symptoms.
This trial tests a new device that uses gentle electrical pulses (PFA) to treat prostate cancer without cutting or heat. It is for men with various risk levels who haven't had other prostate cancer treatments.
This trial tests new treatment strategies for benign prostatic hyperplasia (BPH, an enlarged prostate) using a special MRI scan and a medication called finasteride. It aims to find better ways to manage symptoms and identify markers that predict response.
This trial tests a new device called the FloStent, a small tube placed in the urine channel to help men with an enlarged prostate pee more easily. It's for men who have moderate to severe symptoms and haven't had prostate surgery before.
Hear when a new Benign Prostatic Hyperplasia (BPH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.